NICE approves drugs for Alzheimer's disease

Health authorities and trusts in England and Wales have been told to end the rationing of drugs to treat Alzheimer's disease and to make them available to all patients in whom they might slow the progression of the disease.

The National Institute for Clinical Excellence (NICE) last week issued guidance on the drugs donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl), saying that drug treatment should now form one component of care in people with mild to moderate symptoms.

Treatment …